These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18325660)

  • 1. The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders.
    Slavin S; Kurkalli BG; Karussis D
    Clin Neurol Neurosurg; 2008 Nov; 110(9):943-6. PubMed ID: 18325660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.
    Karussis D; Kassis I; Kurkalli BG; Slavin S
    J Neurol Sci; 2008 Feb; 265(1-2):131-5. PubMed ID: 17610906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience.
    Karussis D; Kassis I
    Clin Neurol Neurosurg; 2008 Nov; 110(9):889-96. PubMed ID: 18375051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
    Kassis I; Grigoriadis N; Gowda-Kurkalli B; Mizrachi-Kol R; Ben-Hur T; Slavin S; Abramsky O; Karussis D
    Arch Neurol; 2008 Jun; 65(6):753-61. PubMed ID: 18541795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
    Karussis D; Slavin S
    J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection in multiple sclerosis.
    Karussis D; Grigoriadis S; Polyzoidou E; Grigoriadis N; Slavin S; Abramsky O
    Clin Neurol Neurosurg; 2006 Mar; 108(3):250-4. PubMed ID: 16413962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of stem cells for the treatment of multiple sclerosis.
    Karussis D; Kassis I
    Expert Rev Neurother; 2007 Sep; 7(9):1189-201. PubMed ID: 17868017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells as treatment for MS - progress to date.
    Uccelli A; Laroni A; Freedman MS
    Mult Scler; 2013 Apr; 19(5):515-9. PubMed ID: 23124791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it too soon for mesenchymal stem cell trials in people with ALS?
    Badayan I; Cudkowicz ME
    Amyotroph Lateral Scler; 2008 Dec; 9(6):321-2. PubMed ID: 18819027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.
    Xiao J; Yang R; Biswas S; Qin X; Zhang M; Deng W
    Int J Mol Sci; 2015 Apr; 16(5):9283-302. PubMed ID: 25918935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL; Wiendl H
    Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study.
    Mohyeddin Bonab M; Yazdanbakhsh S; Lotfi J; Alimoghaddom K; Talebian F; Hooshmand F; Ghavamzadeh A; Nikbin B
    Iran J Immunol; 2007 Mar; 4(1):50-7. PubMed ID: 17652844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for neurological diseases.
    Villoslada P; Moreno B; Melero I; Pablos JL; Martino G; Uccelli A; Montalban X; Avila J; Rivest S; Acarin L; Appel S; Khoury SJ; McGeer P; Ferrer I; Delgado M; Obeso J; Schwartz M
    Clin Immunol; 2008 Sep; 128(3):294-305. PubMed ID: 18534912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult stem cell therapies for neurological disorders: benefits beyond neuronal replacement?
    Boucherie C; Hermans E
    J Neurosci Res; 2009 May; 87(7):1509-21. PubMed ID: 19115417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of LIF in multiple sclerosis.
    Slaets H; Hendriks JJ; Stinissen P; Kilpatrick TJ; Hellings N
    Trends Mol Med; 2010 Nov; 16(11):493-500. PubMed ID: 20870461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in pathogenesis and therapy of multiple sclerosis].
    Linker RA; Stadelmann C; Diem R; Bähr M; Brück W; Gold R
    Fortschr Neurol Psychiatr; 2005 Dec; 73(12):715-27. PubMed ID: 16355314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell-based cell therapy in neurological diseases: a review.
    Kim SU; de Vellis J
    J Neurosci Res; 2009 Aug; 87(10):2183-200. PubMed ID: 19301431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoablation and hematopoietic stem cell transplantation in the treatment of multiple sclerosis].
    Kozák T; Havrdová E; Pitha J; Gregora E; Pytlík R; Maaloufová J; Kobylka P; Vodvárková S
    Cas Lek Cesk; 2000 May; 139(9):263-6. PubMed ID: 10953423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP3 gene expression in multiple sclerosis patients pre- and post mesenchymal stem cell therapy.
    Mohajeri M; Farazmand A; Mohyeddin Bonab M; Nikbin B; Minagar A
    Iran J Allergy Asthma Immunol; 2011 Sep; 10(3):155-61. PubMed ID: 21891821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regeneration and repair in multiple sclerosis: the role of cell transplantation.
    Pluchino S; Zanotti L; Brini E; Ferrari S; Martino G
    Neurosci Lett; 2009 Jun; 456(3):101-6. PubMed ID: 19429143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.